Urogen Pharma Ltd. (URGN) Insider Trading

Last 12 months

Insiders sold $4.77M and bought nothing on the open market.

27% of the selling was scheduled in advance under 10b5-1 plans. Chief Medical Officer Mark Schoenberg sold $2.85M on Aug 20, 51% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2021.

Net open-market

−$4.77M

0 buys · 11 sales

Under a 10b5-1 plan

27%

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Nov 2021

Nov 18, 2021

Get an email when URGN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 8	Chris Degnan Chief Financial Officer	SoldNo plan	2,202	$36.69	$81k	33%	Form 4
Sep 8	Mark Schoenberg Chief Medical Officer	SoldNo plan	871	$42.92	$37k	1.4%	Form 4
Sep 8	Jason Drew Smith General Counsel	SoldNo plan	1,519	$42.54	$65k	2.8%	Form 4
Aug 20	Mark Schoenberg Chief Medical Officer	SoldNo plan	60,677	$47.05	$2.85M	51%	Form 4
Jul 9	Mark Schoenberg Chief Medical Officer	Sold10b5-1 plan	10,000	$40.00	$400k	7.7%	Form 4
Jun 22	Mark Schoenberg Chief Medical Officer	Sold10b5-1 plan	10,000	$35.01	$350k	7.2%	Form 4
Jun 8	Mark Schoenberg Chief Medical Officer	SoldNo plan	5,222	$27.30	$143k	3.6%	Form 4
May 8	Mark Schoenberg Chief Medical Officer	Sold10b5-1 plan	10,000	$30.00	$300k	6.9%	Form 4
Feb 3	Jason Drew Smith General Counsel	SoldNo plan 3 parts	7,479	$19.69 average	$147k	12%	Form 4
Feb 3	Mark Schoenberg Chief Medical Officer	SoldNo plan 3 parts	7,373	$19.69 average	$145k	4.8%	Form 4
Nov 19, 2025	Mark Schoenberg Chief Medical Officer	Sold10b5-1 plan	10,000	$25.00	$250k	6.7%	Form 4
Oct 8, 2025	Chris Degnan Chief Financial Officer	SoldNo plan	2,203	$16.85	$37k	49%	Form 4
Sep 8, 2025	Mark Schoenberg Chief Medical Officer	SoldNo plan	871	$19.11	$17k	0.6%	Form 4
Sep 8, 2025	Jason Drew Smith General Counsel	SoldNo plan	1,520	$19.11	$29k	3.4%	Form 4
Aug 11, 2025	Mark Schoenberg Chief Medical Officer	SoldNo plan	10,000	$17.69	$177k	6.3%	Form 4
Jul 28, 2025	Jason Drew Smith General Counsel	SoldNo plan	7,522	$19.14	$144k	15%	Form 4
Jul 28, 2025	Mark Schoenberg Chief Medical Officer	SoldNo plan	5,149	$19.14	$99k	3.2%	Form 4
Jun 9, 2025	Mark Schoenberg Chief Medical Officer	SoldNo plan	5,162	$7.37	$38k	3.3%	Form 4
Jan 31, 2025	Mark Schoenberg Chief Medical Officer	SoldNo plan 3 parts	4,551	$11.14 average	$51k	3.0%	Form 4
Jan 31, 2025	Jason Drew Smith General Counsel	SoldNo plan 3 parts	7,379	$11.14 average	$82k	18%	Form 4

Oct 8No plan
Chris Degnan
Chief Financial Officer · sold 2,202 at $36.69
$81k
33% of stake
Sep 8No plan
Mark Schoenberg
Chief Medical Officer · sold 871 at $42.92
$37k
1.4% of stake
Sep 8No plan
Jason Drew Smith
General Counsel · sold 1,519 at $42.54
$65k
2.8% of stake
Aug 20No plan
Mark Schoenberg
Chief Medical Officer · sold 60,677 at $47.05
$2.85M
51% of stake
Jul 910b5-1 plan
Mark Schoenberg
Chief Medical Officer · sold 10,000 at $40.00
$400k
7.7% of stake
Jun 2210b5-1 plan
Mark Schoenberg
Chief Medical Officer · sold 10,000 at $35.01
$350k
7.2% of stake
Jun 8No plan
Mark Schoenberg
Chief Medical Officer · sold 5,222 at $27.30
$143k
3.6% of stake
May 810b5-1 plan
Mark Schoenberg
Chief Medical Officer · sold 10,000 at $30.00
$300k
6.9% of stake
Feb 3No plan
Jason Drew Smith
General Counsel · sold 7,479 at avg $19.69
$147k
12% of stake
Feb 3No plan
Mark Schoenberg
Chief Medical Officer · sold 7,373 at avg $19.69
$145k
4.8% of stake
Nov 19, 202510b5-1 plan
Mark Schoenberg
Chief Medical Officer · sold 10,000 at $25.00
$250k
6.7% of stake
Oct 8, 2025No plan
Chris Degnan
Chief Financial Officer · sold 2,203 at $16.85
$37k
49% of stake
Sep 8, 2025No plan
Mark Schoenberg
Chief Medical Officer · sold 871 at $19.11
$17k
0.6% of stake
Sep 8, 2025No plan
Jason Drew Smith
General Counsel · sold 1,520 at $19.11
$29k
3.4% of stake
Aug 11, 2025No plan
Mark Schoenberg
Chief Medical Officer · sold 10,000 at $17.69
$177k
6.3% of stake
Jul 28, 2025No plan
Jason Drew Smith
General Counsel · sold 7,522 at $19.14
$144k
15% of stake
Jul 28, 2025No plan
Mark Schoenberg
Chief Medical Officer · sold 5,149 at $19.14
$99k
3.2% of stake
Jun 9, 2025No plan
Mark Schoenberg
Chief Medical Officer · sold 5,162 at $7.37
$38k
3.3% of stake
Jan 31, 2025No plan
Mark Schoenberg
Chief Medical Officer · sold 4,551 at avg $11.14
$51k
3.0% of stake
Jan 31, 2025No plan
Jason Drew Smith
General Counsel · sold 7,379 at avg $11.14
$82k
18% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch URGN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

SLNOSoleno Therapeutics Inc

AMRNAmarin Corp PLC\Uk

ABUSArbutus Biopharma Corporation

CYRXCryoport Inc.

LFVNLifeVantage Corporation

MRVIMaravai Lifesciences Holdings Inc.

VNDAVanda Pharmaceuticals Inc.

IDYAIdeaya Biosciences Inc.

Spot a number that looks wrong? Check it in URGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing URGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.